tv On the Move Bloomberg April 22, 2014 3:00am-4:01am EDT
3:00 am
the yen is a little lower. there seems to be this next move building on last week. we have been away for four days. they seem to be building on those gains in the u.s. >> futures are indicating a higher start. a lot of focus on pharmacy. up withare teaming glaxo to streamline the health care venture. a lot of news this morning. the takeaway is they are streamlining the business. the process started a year ago. they are selling off smaller units. the ceo of the year told us is about integration. >> i think for the moment stocks have changed. it's unclear whether it is open and unchanged or unchanged because it hasn't opened yet. that is one company we are watching. there are a handful of other stories we are watching. beingker of botox is targeted for takeover by valium
3:01 am
pharmaceuticals. bloombergd a nice scooped saying pfizer the largest drugmaker held talks with astrazeneca. in terms of the corporate watchingwe are phillips. >> this is one of the biggest lighting companies. they missed on their earnings. they missed on sales and foreign exchange. the ceo was with us a little earlier. exactn't have an valuation. the top line is they missed. the evenh care business, though the auto business is going better, the health care business is at a low. >> it's actually not open yet,
3:02 am
but we will expect celebs to keep the share price open any time now. another very nice bloomberg scoop. we understand we have a new ceo at ford. >> exactly. man whoally, the brought ford back from the brink is going to hand over the reins to mark fields. he is the chief operating officer. he has got ford in his blood. 25 years he has been at the company. he really turned around the thorn in their side. the u.s. unit is incredibly profitable. the weekly business review at fort. going to be taking the reins. >> since he is taking on such a big role, it is a continuation of what we see. we have a couple of corporate stories. we are watching central bank.
3:03 am
ukraine doesn't seem as smooth as we thought it was just two weeks ago. >> the whole rhetoric seems to be a rerun of what happened. almost the markets are tacitly accepting. that may escalate to head-to-head conflict. little bitving a lower with some data in europe. we are going to get european consumer confidence data later today. be bernanke is going to speaking to the economic club of new york. talk aboutoing to phillips. market movers.e >> definitely one of the market movers. pharma is going to be one of the critical issues. let's go straight to some of the stock stories. that is what the market is going to be focused on. a $15 billioning
3:04 am
deal in terms of buying the cancer business. shareholders will receive benefits from the proceeds of the $16 billion, so novartis paid $16 billion for the oncology business. overall you are seeing health rise at the same time, selling part of their business. and selling the consumer health business between the two. really seeing a big focus in terms of health care. story that they are talking to private equity companies about taking part of their bad loans, parceling them into a vehicle that can be sold off. we have seen them create bad banks internally. it was down five percent.
3:05 am
they are now declining further. this is one of the biggest lighting companies. they missed by over a quarter of a billion in euros. they have missed 5.2 in terms of the top line. keyign exchange was the issue for them in terms of challenges along with the issues in russia and china. again, that's the news coming through. the dollar overall was trending higher. we are seeing that come back a little bit lower. moving a slightly different direction. it's definitely all about health care. the ceo spoke to us this morning, and he said he would look at acquisitions as well. >> there you go. inc. you. joining us for more perspective on the markets, the global market strategist.
3:06 am
they invest about 1.6 trillion dollars of assets. thank you so much for coming. let's get a feel for how the market feels this morning. aboutl talk a little bit the corrections, but it seems the overarching theme is markets deciding to ignore geopolitics because of the fed, because of central banks because they are firmly behind everything. >> you have a few pillars that underlined this market. you have broadening economic growth, and with all of that put together you are going to see markets pushed back geopolitics. that said, if you look -- >> is that worrying? >> it doesn't worry me because if you look at the transition mechanisms for how something like ukraine or russia plays out in the broader financial markets, the main one is an energy play that impacts europe a little bit, but the country
3:07 am
taking it the hardest is russia. i think investors can sidestep some of those problems. aroundt of the countries the world are going to wait until this is over to try to sell more cheeseburgers and automobiles. that is more concerning in europe is the comment from phillips about currency. something that kind of worries me, depending on how you measure it about half of revenues from europe come from outside of europe. when you have a strong euro that is a problem. >> we will talk about that today. here is a look at what else is coming up. glaxo all or nothing billion dollar deals. lights out for phillips. the company's outlook for shareholders down express and.
3:11 am
are a handful of companies on the move. in terms of stock prices, higher.eca is i am going to run through the main news we had in the market. novartis selling its vaccine. it is buying the oncology unit. we have a slew of other m&a activities. people claiming they were looking at mergers. the pharmaceuticals are doing pretty well. it is the first report since the less carrier.
3:12 am
joining us for a preview is jonathan. >> don't be fooled. the share of the market in china has been contracting somewhat. you have got to say the only reason we are talking about this company is it has a multi-hundred million subscribers and apple has finally got be iphone in the game. no big cues. that's because it was already on sale in china. there were one million pre-orders for the device in january. that is what the market and everybody invested really cares about. iphone sales expected at 37.7 million units. ipads 20 million. a lot of tech companies would be
3:13 am
happy to be that in a year, let alone a quarter. it's about getting those clues. >> thank you so much. for more of his views on the market is the global market strategist with jpmorgan. when you look at china mobile, three quarters of the story is a play on china, but the other half is a play on tech. should we start with china? are you worried you may see a slowdown that is a little bigger than what the government is predicting? >> yes, that's a concern. we know china has to tackle some big problem's. they have to tackle pollution. it is going to slow growth, but i think we need to start looking at quality of growth rather than quantity. chinaou are seeing with mobile is the continuation of a strong underlying consumer
3:14 am
trend. more people are getting access personal technology, apparel, automobiles, so while overall growth in china may be slowing, plenty of opportunity for investors to take advantage. a goodthe government has handle on this. you are focusing on holiday growth but without the hard landing. >> china has the resources. they have the reserves. they have the will to basically protect us from a sharp decline. i don't have as much confidence as i wish i did in the headline gdp figures. itsmately, china will put foot down. we are seeing signs of maturity in terms of allah see effects. they are sacrificing topline growth to make reforms needed. >> when you look at the tech stocks, what is the biggest trend? to 2000, orest back
3:15 am
do you just need to find better value? >> one of the things we were trying to talk to clients about, if you look at the nasdaq index, it is more diversified than 2000 the tech heavy. that selloff happened, the biotech sub industry group lost 16 points off its ratio. what that tells you is this is a much more discerning market. the selloff is much more contained. it is smarter. it's healthy, unlike 2000, where it was a bloodbath across-the-board. about the tech industry. then you have netflix. you have a lot of company's branding themselves as tech companies. where do you see the companies that are the next frontier or the next big thing? >> and is a leveraged to a stronger consumer going forward,
3:16 am
the other thing we are noticing is if you look at companies spending on r&d and, basically companies finding a way to fight the pie areece of outperforming. investors are trying to dig through. if there is a recession people are still going to buy their phone or their gadget. >> that's a good point. another company on the move this morning is phillips. first quarter profits missed estimates on currency troubles. manus cranny joins us with the latest. message on a strong foreign exchange. he kind of justified it because of these weak earnings. >> i think he has touched on this, which is a concern that the ceo is making loud noise. is the biggest one-day drop
3:17 am
since 2011. they missed on health care. margins are at an 11 quarter low. they are saying it is encouraging in terms of the health outlook, but it is doing nothing for the stock this morning. i think when it comes to the geography of where the challenges are, very much touching on the conversation you were just having. china and russia are two critical areas. we saw the economy continued to slow down a bit, and that especially is noticeable in infrastructural projects. our lighting business suffers from that. the consumer market was still going strong, especially as we have innovation such as air hot product in a much demand. russia we see across-the-board reduction in demand further
3:18 am
theavated by the fall of ruble, so that's where we see a double whammy. up free of thep big messages. what was about the value of the euro. the second, it's no longer just about light bulbs. it's about citizen -- systems. that's what they want to be involved in. also, the biggest selling item on the block. i quite like that. >> what's the next frontier for a lot of these companies? i guess big city deals are the battleground for a lighting company. >> washington has just changed the light program. the usage of power is going to go down. they awarded the contract to phillips. 13,000 bold. think of the sistine chapel. they are going to like the sistine chapel. and the sistine chapel.
3:19 am
huge contracts which involve engagement. a real relationship between the two. the provider of lighting, the systems, the technology, and the company that actually needs lighting support. just think about walmart. rats, -- rathscom, ge. who would have thought there was so much money in a lightbulb? i know. i am replace it with led. they are not cheap. i have the altar at one and. back to you. >> thank you so much. i wonder how many light bulbs in paris. you look at some of these
3:20 am
companies, you mentioned at the start you were a little concerned by the fact that they mentioned the high euro as a real concern. it, butin talking about this is becoming a real problem. draghi wanted to tackle it. he hinted at it. >> i think they are going to do something. if you think about it, the ecb has been a bit of a victim of its own success in the sense that this crisis is behind us. you had the successful greek bond option. you had banks making early repayments. pouring in and actually boosting and holding up the euro. for thericky problem ecb. the better things get the more capital europe is going to attract. the stronger the euro gets the
3:21 am
more of a head wind going to be. it's a real tricky challenge for them. >> the dollar should go up, and it hasn't for no apparent reason. are we going to see a higher dollar? >> we think so. i have had that wrong last year. i thought we would last year, but this year we have less this cool dragon the u.s. economic data is back on track after a nasty winter. things should be improving. the dollar should strengthen, in particular with the fed winding down qe. >> that's what they think. it's one of these miracles in the currency market. take you so much. coming up, the new ceo in the driver seat. legacy.at malawi's
3:24 am
3:25 am
>> jo hendrickson all the people you know, they are probably the finest leadership team in the world, and they are developing nicely. i am very proud of them. >> for more on the leader at the car company and the tough act he has to follow, our european business correspondent caroline hyde. this is a nice bloomberg scooped. willderstand mark fields be the new ceo. >> as soon as may 1 we could hear him knighted as the new chief executive designate. we understand alan mulally will .tay on board this is a man has -- stay on board a little longer. this is a man who has ford in his blood. following in the footsteps of alan mulally, 15 years his senior, who is really deemed to have brought the company back from the break.
3:26 am
>> is this a surprise? >> perhaps not. he has a record already at ford. he has been leading the north american unit for nine years. it was a thorn in his side at ford and he managed to bring it back as well. he is a turnaround king as well, similar to alan mulally. it is now $8 billion in profit. boast one of to the best margins of profitability in the entire industry, so mark fields clearly has the expertise he needs to drive forward. businessy takes the review call once a week so it seems like he has got the the company. >> thanks for the latest on ford and the new ceo. as we head to the break, astrazeneca, glaxo, all moving off the deals. we will have more coverage from
3:27 am
3:30 am
>> welcome to "on the move." i am francine lacqua. we are 30 minutes into the trading today. how things are shaping all. this is the marks overall. we are seeing a lot of agreement. investors are watching central-bank action. and brushing aside lyrical tensions in ukraine. aside political tensions in ukraine. let's dig a little deeper. manus cranny has the touchscreen. >> have a look at this. the industry groups. health care rising by over 0.5%.
3:31 am
at the other end, health. technology up by 0.8% lead higher. is all about pharma. that is the key driver. novartis doing a deal with glaxosmithkline. pastors in the cut is the other story of the bloomberg west -- astrazeneca is the other story on the bloomberg screen. they had discussions last year. it is said that has gone off of the board. astrazeneca and glaxo got together. high in the u.s., novartis. it is at a 10 year high in the first quarter. philips, the other stock. they are down 5.5%. they missed targets.
3:32 am
back to you. >> thank you. banks have biggest agreed with the policeman every agreement and restructuring advisor. according to "the financial times," they will pull their bad loans. it could combine several billion of euros. announce a plan to exit its business today according to "the new york times." it would join jpmorgan and inling its marquee business the face of falling profits and increase regulation. joe biden is meeting with ukraine's prime minister and president today. as an agreement to ease tensions and the ukraine. weekeal reached last called for illegal groups to give up their arms and return seized buildings and several
3:33 am
eastern ukrainian city. probe russian forces have held their ground saying they are not -- pro-russian forces have held their ground saying they are not backing down. julianna goldman is in kiev following the vice president of -- vice president biden's spe ech. >> the vice president finished up a meeting with ukraine's acting president and speaker at his meeting with a group of legislators from a wide variety of parties and regions including three of the presidential candidates and the may 20 fifth elections. the goal is to show unity with ukraine after the highest levels of u.s. government. also speaking to how the u.s. can help the ukraine from a russian energy pressure, help , andup the first economy fair elections next month. they will also be discussing more ways that the u.s. might be
3:34 am
able to revive and nonlethal assistance. we've expect the vice president to call for urgent implementation of the geneva accord last week that you were referring to. the administration said so far they have not seen progress on that front. the next step would be to impose the next round of sanctions. bey are saying it will determined within a matter of days, not weeks. the indication it will be later to work the end of this week. they want to wait a couple of days after the vice president returns. fox talks us about the size of the aipac. how significant is it? >> it is being described as in a package that relies on technical assistance. advice toking about help ukraine on energy diversification. there are teens on the ground advising on reverse issues. the vice president in his imaginejust now said
3:35 am
the u.s. stands ready to help ukraine on energy and imagine if right now they are in a position and they can say to russia, you keep your gas. on a economic, the loan guarantees. the imf assistance. the u.s. is saying they want to make sure the money is allocated in an effective way to measure interest in the east and the for. are accounted that goes to the other mess of a biden which it is so important for ukraine to be presented a united front -- message of biden which is it is so important for ukraine to be presented as a united front. and for sizing the government has to do a better job of nottaining that unity and give any excuses to russia for further intervention. >> julianna, thank you so much. vice president biden also saying that the u.s. is ready to aid ukraine on energy matters and
3:36 am
also saying the u.s. does not s ukraine but is there to support them. we expect an official speech within the hour from vice president biden. it looks like we will be up to get it to you. let's return to one of our top market stores. of m&a.ove to a slew they are forming a consumer group. we spoke to the novartis' chief executive. the first interview of the day. >> what we announced is going to keep us very busy for the foreseeable future. we are planning integration and the integration of the businesses. that will take the next 9-12 months. i think is important that we announced today is the conclusion of the portfolio review that we have done, announced about a year ago for
3:37 am
our current products. that is not to say we are not going to participate in other m&a going forward after we digest and plan of this. we have sent our strategy in m&a is to add acquisitions to our big, important businesses. and that will continue. now that we have pharmaceuticals and we have eyecare and generics as big, important businesses, this going to help us on the m&a front if you think of them going forward. to discussus now novartis and the other farmer pharma deals is sam. matt, let's kick it off with you. this is novartis streamlining, selling off to yet and said they are ready -- 2 younis and send they are ready to sell off. but this is actually 4
3:38 am
transactions in one day which is remarkable for any company especially a company that has been going through as a joe him and has mentioned this portfolio review. ishe alluded to, the company built around a visa three big businesses. they do have a roadmap going for. the question becomes, the pharma sector is very rapidly moving dynamic sector. no one is standing was dealt -- still as we have seen from other companies. this a very fast-moving sector. whether it is enough for novartis to keep going is the big question. and were is a lot of m&a learned that pfizer was looking into a deal. it has now stopped. what does it mean for novartis? the strategy is clear but
3:39 am
fast-moving. do they have it right? >> two or three things they have done has been in line with what they have been saying. realizing value. getting rid of the subpar animal business. also with regards to the other business. the one surprise with the oncology deal which i do not think -- perhaps if we go back and read between the lines and what the company has said, that is where the surprise was. the other units that have been going on with restructuring and getting value and the best in what they have. oncology was interesting. what they sell -- they bought from glaxo to stop -- and glaxo. are they overpaying? numbers.ed at the if you do not include the milestone payment of $14.5 billion, is around nine times,
3:40 am
over nine times sales for college stuff that is a very chunky number. i think what is driving this is the excitement about the potential combinations of other products. if you remember, novartis about a company-- bought .hich is trying to treat cancer very revolutionary way. of whate combinations glaxo brings to the table and novartis has that could be quite exciting. what isis probably driving this. >> will we see many more deals? we sigh he is looking for other bold decisions. z ise saw that mr. jimene looking for other bold decisions. they are looking for other drugs. >> the deals are in the air. one of the scenes we have been
3:41 am
following, pfizer and astrazeneca and the talks which are now dead. and everything with novartis is these chief executives and pharmaceutical sectors are ready to make very big decisions. they are dusting off these six files on big transactions that they have had on the shelf for years. now is a time to do that. we have seen that and other industries notably technology this year. i think at this point, you would not be wrong to bet on a more m&a. >> one a quick thing. ceos talkpanies' about undone deals. just to get himself that bit of cushion. they are often questioned. >> it drives up prices, sound. >> it weren't for the two companies today. >> and that is very true. it is basically given the flavor.
3:42 am
>> i think we've had enough today. >> for now. big -- small can become big. companies would've never heard market $10 billion plus caps. >> a very true. thank you so much. matt campbell and sam sizelli. other countries on move. profitsposted record -- that missed estimates. the largest lighting company said 20 42 will be a challenging -- 2014 should miss will be a challenging year but should make the targets. cracking down on carlos slim' american mobile. they said the company is not obeying regulation. telephone call wants the government to force american mobile to follow the rules will
3:43 am
3:46 am
>> i am francine lacqua. this is "on the move." netflix got a boost in after-hours trading on the heels earnings thater beat estimates. caroline hyde, it is embedding a can lead to more users to its exclusive content. upthat is why we saw shares after hours because they are hoping they can bring out more profitability from each of the users they have. they already have more than 48 million subscribers. they are going to add about 25% in terms of the price they charge. dollar.ar-two you can do a limited web
3:47 am
viewing. they are the bigs online subscription service. onlinebiggest subscription service. also profit a beat. times, at $50 million. sales grew 24%. it looks to be able to grow in its exclusive content and lure people in. >> is international growth is also growing. as that is interesting. the pace is picking up up 16% we saw growth of international subscribers in the first quarter. we are seeing half of that for the united states although domestic is where they are strongest. 75% of all of their subscribers are based in the united states. they want to drive that to more than double. they want to get 60,000,000-90,000,000 in the u.s. six percent growth in the first quarter.
3:48 am
interestingly, the focus is on europe. germany, they are likely to enter in september. france and by autumn. think of the amount of broadband users in those two countries. 30 million and germany. that is why they want to cap -- tap europe and from my after the situation. really cultivate the expansion. they already have the nordic and netherlands, they really want to expand in terms of europe as well. afterx up almost 7% hours. techs been affected by the stock in the united states. it allows 21% of its value in march. it is based on the growth. it is a company with $50 million worth of quarterly profits. it is valued at $20 billion. a lot of investors wanting to see the profitability grow and
3:49 am
he can do that if the charges more for its customers. >> thank you so much. after hours gaining 6.8%. let's keep the congress -- conversation on netflix. basedo of a movie streaming service. will pay for a smaller, hand-picked selection of films. thank you for joining us on the program today. you used to be in finance. you look at the numbers and the model. you try to differentiate yourself from netflix. netflix is doing very well as long seven exclusive content they generate. model is quitess challenging because they need to aggregate a lot of content. in order to create a valuable position that makes sense. , theyu see the numbers expect $3 billion on contact -- content of this year.
3:50 am
we think it is going to be very difficult for netflix to grow internationally as fast as they onh spending that much money content. we differentiate ourselves and he had to go to these countries and growth? ours is based on a limited selection of films. there are 30 phones you can watch. >> i know you launched, you are on mobile. about netflix. if you do not see the company, look what i have seen. how much of a buzz do you need? how much of a name? content.ed really good you betrayed a library of content that is appealing. what we are doing is telling the paradox out of the equation. -- you create a library of content that is unappealing. you may not find something and the original content -- has
3:51 am
great content and is valuable to have everything. they do not have everything. its disciplines and a lot of people. >> they have the blockbusters. your selling point is i am not cheaper but i have a higher value -- do you feel under pressure to have a bit more almostogical, you know, like a venture with some of these apple tv's are -- or smart tvs? >> you need all the devices that matter that people are engaged. it is the service was. it is the duration. ?> like a beauty -- boutique >> it is a boutique of films. your time is valuable. if you do not watch many movies and you want to trust it. it is very quick to become commoditized. we think there is room for quality. >> adjusting business model.
3:52 am
efe cakarel there. pulse" is coming up in 10 minutes. i am joined by my co-anchor. we'll be talking pharmaceutical and ukraine. quips is only one thing that people is talking about -- >> it is only one thing that people is talking about. it is on twitter that he will leave the club. over 30en retweeted 5000 times. caroline hyde just told me. and football media and business store. we'll cover all of that. and the technology angle. her take on what is going on in london and the broader tech scene. a nice show is coming up. looking forward to it. >> thank you so much. i am looking forward to it. little football. we're back in a couple of minutes. ♪
3:55 am
3:56 am
very good friends with all of them. we wanted to make something exclusive. of card to be luxury and performance and design. we have seven under 70 horsepower. it can reach 400 kilometers per hour. we have 770 horsepower. we get our rubies and emeralds put inside of the lights. we are 24 hours -- that comes with the car. it is only 100 members. with a 200,000 dollars watch which is in a limited edition. it is completely handbuilt. over 600 hours. 600 hours to paint the car. hologram. it was developed by a university. it can fly into the air.
4:00 am
72 Views
IN COLLECTIONS
Bloomberg TV Television Archive Television Archive News Search ServiceUploaded by TV Archive on